Mehak Trehan, Associate Consultant at Fortis Healthcare, shared a post on X:
“Today we launched the Centre of Excellence for Myeloma and Lymphoma at Fortis Healthcare, Gurugram, India.
And the timing could not feel more relevant.
EHA2026 is reminding us that myeloma care is no longer about asking-“What is the next drug?” It is about asking- “For this patient, at this moment, what is the smartest sequence?”
That is where focused myeloma care matters.
Global data is important. But Indian patients, Indian realities and Indian outcomes must shape our own practice.”
Other articles about Myeloma on OncoDaily.
